Systemic Lupus Erythematosus-Associated Thrombotic Thrombocytopenic Purpura: A Case Report. [PDF]
Es-Saad O +4 more
europepmc +1 more source
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP. [PDF]
Postmus T +9 more
europepmc +1 more source
Progression From Early Multiterritorial Punctate Infarcts to Massive Stroke in Fulminant Thrombotic Thrombocytopenic Purpura Despite Aggressive Therapy: A Therapeutic Dilemma in Initiating Antithrombotic Therapy. [PDF]
Luan Z.
europepmc +1 more source
An observational, non-interventional, multicenter, multinational registry of patients with atypical hemolytic uremic syndrome: methodology [PDF]
Ardissino, Gianluigi +10 more
core
Agents of shield: glycans mask antibody epitopes on ADAMTS13. [PDF]
Kretz CA.
europepmc +1 more source
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients [PDF]
core +1 more source
Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy. [PDF]
Tanaka H +9 more
europepmc +1 more source
Beyond the Limits of Conventional Coagulation Tests: A Comprehensive Overview of ACLF-Related Coagulopathies. [PDF]
Kurpiewska D +3 more
europepmc +1 more source
A predictive algorithm involving lactate dehydrogenase to serum creatinine ratio may assist in identifying patients with thrombotic thrombocytopenic purpura. [PDF]
Chen X +8 more
europepmc +1 more source
Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke. [PDF]
Patel RB +9 more
europepmc +1 more source

